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Future drugs from the sea
Several marine chemicals are likely candi­
dates for future drugs. Here are a few being 
explored by US scientists.
• Discodermolide from the Bahamian sponge
Discoderm ia dissoluta  is a powerful 
immunosuppressive agent that may have a 
future role in suppressing organ rejection 
after transplant surgery.
• Bryostatin from the
West Coast bryo­
zoan (moss animal)
Bugula neritina and 
didemnin B from a 
Caribbean tunicate 
of the genus Tridi­
demnum are both in 
clinical trials as can­
cer treatments.
• Pseudopterosin E from
the Caribbean gorgo­
nian coral Pseudo­
pterogorgia e lisa­
bethae and scala­
radial from dictyo­
ceratid sponges 
found in the western 
Pacific are both be­
ing studied as 
anti-inflammatory agents.
• Dolasstatin from the sea hare Dolabella
auricularia and ecteinascidin from the 
tunicate Ecteinascidia turbinata have pend­
ing clinical trial application as anti-cancer 
compounds.
• Halichondrin B from the sponge Lissodendoryx
(and others) and halmon from the red algae 
Portieria hornem annii have reached 
preclinical trial stage as anti-cancer com­
pounds.
Other marine chemicals are being investi­
gated in Europe and in Japan, but we know less 
about the progress of these studies. There ap­
pears to be no shortage of marine chemicals that 
are potential candidates for drugs. The problem 
is that so many chemicals show promising activ­
ity in the initial screens that it is very difficult to 
predict which will become truly significant discov­
eries.
It seems inevitable that economic consid­
erations will prevent the development of many 
marine chemicals that are very effective but
difficult to obtain. The 
rise and fall of inter­
est in marine 
prostanoids clearly il­
lustra tes this. 
Prostaglandins are 
im portant human 
hormones that con­
trol blood pressure, 
renal blood flow, con­
tractions of smooth 
muscle, and gastric 
acid secretion, and 
are involved in inflam­
mation. When 
prostagladins were 
first isolated from 
sheep seminal tis­
sues, these were dif­
ficult to obtain in even 
minute quantities and were extremely expen­
sive. When closely related chemicals called 
prostanoids were acquired in substantial quanti­
ties from the Caribbean gorgonian coral Plexaura 
homomalla, there was a rush to harvest 
gorgonians, isolate the prostanoids, and convert 
these chemicals into biochemically active 
prostagladins. W ithin a year, however, 
prostagladins were being produced by labora­
tory synthesis, and the marine prostanoids were 
soon forgotten, much to the relief of those who 
value the shallow reef environment’s natural 
beauty. This episode provided a valuable lesson 
for entrepreneurs seeking new pharmaceuticals
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The discovery of a new drug 
from an organism's 
molecular structure will not 
mean a mass harvesting of 
the oceans. Scientists will 
eventually culture the 
organism or synthesize its 
molecular structure in the 
laboratory.
- Dr. Paul Scheuer, University of Hawaii 
Makai 15(7) July 1993
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SOME MARINE TOXINS... FROM PAGE 14
describes a potent poison found in seaweed 
known as limu-make-O-Hana (the deadly sea­
weed of Hana). The islanders of old smeared the 
tips of their lances. It was not until 1861 that the 
habitat described in the legend was discovered 
and scientists were able to collect the seaweed. 
Moore and Scheuer isolated the toxin in 1971, 
and its structure was definitively established ten 
years later. Palitoxin has an unusual structure. 
Despite its great molecular weight (around 3,300 
daltons), it is not formed by the repetition of 
simple structural units like polysaccharides. 
Palitoxin is extremely poisonous (LD50 about 0.5 
µg/kg in rats) and possesses antitumoral proper­
ties. A dose of around one-tenth of the minimum 
lethal dose completely cures Ehrlich’s tumor in 
rats. It has recently been used as a local anaes­
thetic in maxillofacial surgery, allowing surgeons 
to operate for several hours at a time. It is a 
powerful vasoconstrictor and is potentially useful 
in the study of angina in animals.
Excerpted from: Luigi Minale. 1985. Medicine from 
the sea. In: SG Richardson (ed). Managing the Ocean; 
Resources, Research, Law. Lomond Publications Inc. Mary­
land 1985.
FUTURE DRUGS FROM THE SEA... FROM PAGE 17
from marine organisms: We should expect ma­
rine chemicals to inspire new drugs rather than to 
provide them.
Chemicals from marine organisms have 
proved to be different from plant sources, and 
have provided valuable tools for biomedical re­
search, as well as inspiration to the pharmaceu­
tical industry. Biochemical studies have posi­
tively influenced marine biology, in as much as 
they have focused attention on marine inverte­
brates and led to pioneering research on inverte­
brate aquaculture and invertebrate-cell tissue 
culture. If we consider the 1980s to be a period 
of basic research on chemicals from marine 
organisms, then the 1990s will surely see new 
drugs and other chemical products that are in­
spired by this research. We will then have 
accomplished our goal of demonstrating the bio­
medical potential of chemicals from marine or­
ganisms without causing any lasting damage to 
the marine environment.
Sources: (1) Oceanus, 1992. Oceanus reports on 
research at the Woods Hole Oceanographic Institution. (2) 
Science Vol. 266. November 25, 1994.
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